| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2009 | WO2005113833A3 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 04/09/2009 | WO2005111112A3 Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases |
| 04/09/2009 | WO2005107474A3 Oncolytic adenovirus armed with therapeutic genes |
| 04/09/2009 | WO2005089441A3 Methods for increasing neurotransmitter levels using hydroxycitric acid |
| 04/09/2009 | WO2005086960A3 Narcotic-nsaid ion pairs |
| 04/09/2009 | WO2005086873A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 04/09/2009 | WO2005074415A3 Antimicrobial, synthetic, fibrous, and tubular medical devices |
| 04/09/2009 | WO2005032496A3 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/09/2009 | WO2005025513A3 Guanidinium derivatives for improved cellular transport |
| 04/09/2009 | WO2005024603A3 Methods for detecting, diagnosing and treating human renal cell carcinoma |
| 04/09/2009 | WO2005005382A3 Compounds, compositions and methods |
| 04/09/2009 | WO2004110360A3 Proteoglycan degrading mutants for treatment of cns |
| 04/09/2009 | WO2004100896A3 Anti-aging nutritional supplement |
| 04/09/2009 | WO2004100895A3 Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders |
| 04/09/2009 | WO2002026020A9 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/09/2009 | US20090093669 Magnetophoresis apparatus and method of use |
| 04/09/2009 | US20090093652 Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093626 High Viscosity Xanthan Polymer Preparations |
| 04/09/2009 | US20090093613 Treatment of tinnitus |
| 04/09/2009 | US20090093549 Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses |
| 04/09/2009 | US20090093548 Colchine compositions and methods |
| 04/09/2009 | US20090093547 Compositions and Methods for Treating Premature Ejaculation |
| 04/09/2009 | US20090093546 Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators |
| 04/09/2009 | US20090093545 Phenoxyalkycarboxylic acid derivatives in the treatment of irritable bowel syndrome or ulcerative colitis |
| 04/09/2009 | US20090093543 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
| 04/09/2009 | US20090093542 Copper antagonist compositions |
| 04/09/2009 | US20090093541 Melanin eliminator preparation |
| 04/09/2009 | US20090093540 Anti-tumor composition |
| 04/09/2009 | US20090093539 Anti-angiogenic compositions and methods of use thereof |
| 04/09/2009 | US20090093538 Method for treating cancer |
| 04/09/2009 | US20090093537 Extracts rich in proanthocyanidins and relating process of preparation |
| 04/09/2009 | US20090093536 Pharmaceutical composition comprising thiacremonone for preventing or treating cancer |
| 04/09/2009 | US20090093535 Method and composition for treating heart failure |
| 04/09/2009 | US20090093534 Mu opioid receptor ligands: methods of use and synthesis |
| 04/09/2009 | US20090093533 Compounds and methods for inhibiting hepatitis c viral replication |
| 04/09/2009 | US20090093531 Co-Solvent Compositions and Methods for Improved Delivery of Dantrolene Therapeutic Agents |
| 04/09/2009 | US20090093530 (2R)-2-[4-Sulfonyl) Aminophenyl] Propanamides and Pharmaceutical Compositions Containing Them |
| 04/09/2009 | US20090093529 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 04/09/2009 | US20090093528 via GM284, nonimmunosuppressive immunophilin ligand |
| 04/09/2009 | US20090093527 [3-(2-{(3S)-3-[2-(Trifluoromethyl)phenoxy]pyrrolidin-1-yl}-1,3-thiazol-5-yl)-1,2,4-oxadiazol-5-yl]methanol, useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disorders, atherosclerosis, obesity, diabetes and fatty liver |
| 04/09/2009 | US20090093526 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 04/09/2009 | US20090093525 N-(1,1-dialkyl-2-arylcyclopropyl)arylcarboxamides, e.g., Chloro-N-[cis-2,2-dimethyl-3-(4-sulfamoyl-phenyl)-cyclopropyl]-2-methoxy-benzamide; nicotinic acetylcholine receptor ligands, particularly positive allosteric modulators for the alpha 7 nAChR subtype |
| 04/09/2009 | US20090093524 Compounds and methods for modulating fxr |
| 04/09/2009 | US20090093523 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 04/09/2009 | US20090093522 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 04/09/2009 | US20090093521 2, 5-Bis-Diamine [1,4] Benzoquinone-Derivatives |
| 04/09/2009 | US20090093520 Plasma carboxypeptidase b inhibitors |
| 04/09/2009 | US20090093519 Methods and Compositions to Inhibit Edema Factor and Adenylyl Cyclase |
| 04/09/2009 | US20090093518 Piperidinyl-substituted isoquinolone derivatives |
| 04/09/2009 | US20090093517 Bis1,2,3,4-tetrahydroisoquinoline derivatives and their uses as pharmaceuticals |
| 04/09/2009 | US20090093516 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | US20090093515 Substituted pyrroline kinase inhibitors |
| 04/09/2009 | US20090093514 Immune response modifier formulations containing oleic acid and methods |
| 04/09/2009 | US20090093513 Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter |
| 04/09/2009 | US20090093512 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders |
| 04/09/2009 | US20090093511 Mast cell stabilizers in the treatment of obesity |
| 04/09/2009 | US20090093510 Use of Nitrooxyderivatives of Drug for the Treatment of Muscular Dystrophies |
| 04/09/2009 | US20090093509 Methods and Compositions for the Treatment of Pruritus |
| 04/09/2009 | US20090093508 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/09/2009 | US20090093507 Cdk inhibitors containing a zinc binding moiety |
| 04/09/2009 | US20090093506 Copper antagonist compositions |
| 04/09/2009 | US20090093504 6-, 7-, or 8-Substituted Quinazolinone Derivatives and Compositions Comprising and Methods of Using the Same |
| 04/09/2009 | US20090093503 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 04/09/2009 | US20090093502 Improved lactate (leucine, arginine, methyl pyruvate, and methyl succinate) usage is accomplished through lactate precursors, adrenergic receptor agonists and insulinotropic agents |
| 04/09/2009 | US20090093501 Heterocyclic antiviral compounds |
| 04/09/2009 | US20090093499 Pharmaceutical composition |
| 04/09/2009 | US20090093498 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one |
| 04/09/2009 | US20090093497 Diacylglycerol Acyltransferase Inhibitors |
| 04/09/2009 | US20090093496 4-[4-[(R)-[1-[(cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine; mixture of rotamers; enriched in certain rotamers by reacting with benzoic, benzenesulfonic, nicotinic, glutaric acid; viricide, inflammation |
| 04/09/2009 | US20090093495 Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases |
| 04/09/2009 | US20090093494 4-Pyrimidineamine Compounds And Uses As Anti-Proliferative Agents |
| 04/09/2009 | US20090093493 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events |
| 04/09/2009 | US20090093492 N-[4-chloro-2-hydroxy-3-(1-piperazinylsulfonyl)phenyl]-N'-(2-chloro-3-fluorophenyl) urea; treating a ELR chemokine mediated disease asthma, chronic obstructive pulmonary disease and adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, or ulcerative colitis, psoriasis |
| 04/09/2009 | US20090093491 Diazine Azole Derivatives, Their Manufacture and Use as Pharmaceutical |
| 04/09/2009 | US20090093489 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 04/09/2009 | US20090093488 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 04/09/2009 | US20090093487 Compositions for topical application having androgenic actions |
| 04/09/2009 | US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| 04/09/2009 | US20090093484 Novel compounds, their preparation and use |
| 04/09/2009 | US20090093483 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4 |
| 04/09/2009 | US20090093482 Therapeutic compositions and methods |
| 04/09/2009 | US20090093480 Insecticidal pyrimidinyl aryl hyrdrazones |
| 04/09/2009 | US20090093479 Anti-cancer agents and uses thereof |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093477 Tetrahydropyrrolopyrimidinediones and their use in therapy |
| 04/09/2009 | US20090093476 Pyrrolo[1,2-a]quinoxaline derivatives as adenosine a3 receptor modulators and uses thereof |
| 04/09/2009 | US20090093475 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals |
| 04/09/2009 | US20090093474 Thiazolyl-dihydro-indazole |
| 04/09/2009 | US20090093473 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 04/09/2009 | US20090093472 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 04/09/2009 | US20090093471 Methods of Treating Nervous Disorders |
| 04/09/2009 | US20090093470 Photodynamic therapy process and photosensitizer compositions therefor |
| 04/09/2009 | US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/09/2009 | US20090093468 Peptide Deformylase Inhibitors |
| 04/09/2009 | US20090093467 Therapeutic compositions and methods |
| 04/09/2009 | US20090093466 Carboxamide GABAa ALPHA2 Modulators |
| 04/09/2009 | US20090093465 Therapeutic kinase modulators |
| 04/09/2009 | US20090093464 Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor |
| 04/09/2009 | US20090093463 Novel compounds of substituted and unsubtituted adamantyl amides |